BD announced the launch of the BD U-500 Insulin Syringe, the first insulin syringe designed for patients with diabetes taking Humulin R U-500 insulin (regular insulin [human, rDNA origin]; Eli Lilly).

BD has issued a recall for the BD Insulin Syringes with the BD Ultra-Fine needle ½mL 12.7mm 30G, Cat (Ref) 328466 with Lot# 6291768. BD has issued a recall for the BD Insulin Syringes with the BD ...

On the heels of the Health Service Medical Supplies (Costs) Act of 2017, effective this month, BD (Becton, Dickinson and Company) announced the BD Viva™ brand of insulin pen needles are now the most ...

For people with diabetes who inject insulin, the syringe and needle size can make a big difference in comfort and staying on track with steady blood sugar levels. According to a 2024 statistics report ...

* Investment will be used for new technology and manufacturing equipment to expand capacity for BD insulin syringes Source text for Eikon: Further company coverage: ...

Medical technology company BD on Wednesday that it will invest $100 million in its plant in Holdrege to expand capacity for its insulin syringe manufacturing operations. The investment will be used ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. BD has increased its manufacturing capacity for critical ...